series-b
Stage
1
Investors
About
WhiteSwell developed the eLym™ System, a medical device designed to enhance lymphatic drainage to reduce tissue and organ fluid congestion in patients with acute decompensated heart failure. The company aimed to improve treatment by creating a low-pressure zone at the thoracic duct outlet to facilitate lymphatic fluid removal during decongestion.
Explore WhiteSwell's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.